Shilpa Medicare Ltd News

Shilpa Medicare rallies 6% on getting API nod from European regulator

Shares of Shilpa Medicare rose 6.23 per cent at Rs 917.20 per share on the BSE in Tuesday's intraday deals

Shilpa Medicare shares climb 8% after multifold profit growth in Q2FY25

Shilpa Medicare's shares surged as much as 8.45 per cent to hit an intraday high of Rs 894.50 per share

Shilpa Medicare shares rise 3% on receiving CEP for Desmopressin; details

Shilpa Medicare share price surged after the company said that its arm, Shilpa Pharma Lifesciences, has received certificate of suitability (CEP) from EDQM for API, Desmopressin

This pharma stock has zoomed 179% so far in CY24; Antique sees more upside

Shares of Shilpa Medicare hit a new high of Rs 922, gaining 4% in Monday's intra-day trade after Antique Stock Broking initiate coverage on the stock with a BUY rating and a target price of Rs 1,300.

USFDA approval sends this multibagger pharma stock to 52-week high

Northward surge in the stock price is attributed to the news that the company has received approval from the US Food and Drug Administration (USFDA) for its product, 'Bortezomib Injection NDA 212782

Shilpa Medicare hits fresh high on successful trial of liver fibrosis drug

Shares of Shilpa Medicare were trading at Rs 733.15, up by nearly Rs 36, or 5.15 per cent on the BSE. In contrast, the 30-stock BSE Sensex was trading at 81,714 levels, up 0.77 per cent.

Shilpa Medicare's stock rallies 8% on successful phase-1 trials of rHA

Shares of Shilpa Medicare soared up to 7.96 per cent at Rs 718.90 per share on the BSE in Wednesday's intraday deals

This pharma stock has surged 16% on Friday; zoomed over 100% so far in CY24

Shilpa Medicare hit a multi-year high of Rs 672.50, rallied 16% after the company's CDMO customer reported positive results from pivotal clinical trial & placed binding purchase order.